Your browser doesn't support javascript.
loading
Cancer embryonic antigen (CEA) levels in patients with appendiceal adenocarcinoma predict response to neo-adjuvant chemotherapy and overall survival.
Egbert, Lena; Norain, Abdullah; Stucky, Chee-Chee; Ahmad, Sarwat; Chang, Yu-Hui; Wasif, Nabil.
Afiliação
  • Egbert L; Mayo Clinic Alix School of Medicine, Phoenix, Arizona, USA.
  • Norain A; Department of Surgery, Division of Surgical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Stucky CC; Department of Surgery, Division of Surgical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Ahmad S; Department of Surgery, Division of Surgical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Chang YH; Department of Quantitative Health Sciences, Mayo Clinic, Phoenix, Arizona, USA.
  • Wasif N; Department of Surgery, Division of Surgical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
J Surg Oncol ; 127(4): 688-698, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36519637

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Apêndice / Adenocarcinoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Apêndice / Adenocarcinoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article